Rockbridge Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Rockbridge Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-120	Closed	-$3.94K	–	154
2023 Q4	$3.94K	Buy	+120	New	+$3.26K	﹤0.01%	489
2022 Q3	–	Sell	-290	Closed	-$9.13K	–	133
2022 Q2	$9.13K	Hold	290	–	–	﹤0.01%	376
2022 Q1	$13.9K	Hold	290	–	–	﹤0.01%	463
2021 Q4	$18K	Hold	290	–	–	﹤0.01%	491
2021 Q3	$22K	Hold	290	–	–	﹤0.01%	438
2021 Q2	$27K	Hold	290	–	–	﹤0.01%	398
2021 Q1	$26K	Sell	290 -180	-38%	-$17.9K	﹤0.01%	376
2020 Q4	$44K	Buy	+470	New	+$37.4K	0.01%	300

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Rockbridge Investment Management's ARKG Position: Q1 2024 in Review

Rockbridge Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 120 shares — an estimated $3.94K sold.

Rockbridge Investment Management first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $44K in Q4 2020. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

Rockbridge Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 120 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $3.94K.
Rockbridge Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
Rockbridge Investment Management's ARK Genomic Revolution ETF position peaked at $44K in Q4 2020.
284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.